G6PD, one of the PPP-related enzymes, is associated with the molecular subtype of breast cancer, and G6PD overexpression is associated with poor prognosis of breast cancer (Pu et al., 2015; Dong et al., 2016). Here, G6PD is linked to breast carcinoma.